News

In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite’s resistance to all antimalarial drugs has posed a big challenge for researchers working to stop the spread of the disease. A team led...

Identification of RNA-binding proteins using R-DeeP reveals new drug targets

UC Riverside-led study zeroes in on special RNA molecules in the human malaria parasite

Mosquitoes spread several diseases, such as malaria and dengue. In 2020 about 241 million cases of malaria occurred worldwide, with a few more million cases occurring in 2021. Nearly half the world’s population lives in regions where contracting dengue virus is a risk. Insects also destroy a third of agriculture...

UC Riverside-led research could lead to novel antimalarial therapeutic strategies

Study co-led by UC Riverside scientist could help develop strategies to combat the disease

UC Riverside-led research could help develop novel therapeutic strategies to combat malaria

UC Riverside’s Karine Le Roch is principal investigator on two NIH grants

A team of researchers led by a University of California, Riverside, scientist has found that various stages of the development of human malaria parasites, including stages involved in malaria transmission, are linked to epigenetic features and how chromatin — the complex of DNA and proteins within the nucleus — is...